Skip to main content

Table 1 The antibacterial and antifungal activities (growth inhibition %) for compounds 7a–k, 8a–c and 9a–c at 32 µg/mL concentration

From: Synthesis and biological evaluation of 2-(4-methylsulfonyl phenyl) indole derivatives: multi-target compounds with dual antimicrobial and anti-inflammatory activities

Compound No.

Saa

Ecb

Kpc

Pad

Abe

Caf

Cng

7a

95.76

96.48

97.64

97.76

96.66

6.28

− 64.35

7b

25.62

− 8.09

− 5.34

3.8

35.54

9.55

− 280.7

7c

21.88

3.17

12.8

11.3

43.29

4.13

− 110.9

7d

15.6

− 5.77

4.86

− 8.11

34.95

2.54

− 177.2

7e

7.58

− 11.49

− 14.6

− 22.55

43.64

28.66

− 59.93

7f

8.33

− 9.43

8.05

− 7.9

66.69

3.5

− 118.8

7g

96.15

86.42

87.53

94.63

85.76

4.88

− 57.42

7h

30.26

− 13.86

23.59

7.97

51.82

25.34

− 99

7i

95.22

96.45

94.4

96.93

94.34

15.32

− 104.5

7j

30.59

− 2.24

12.27

− 0.85

46.23

1.91

− 80.19

7k

28.25

− 0.72

8.77

2.23

31.42

1.79

− 55.44

8a

13.6

− 45.65

− 22.34

− 28.34

− 15.51

7.71

− 292.1

8b

11.28

− 8.78

6.56

14.46

22.42

13.22

− 114.4

8c

4.62

− 25.19

− 8.38

− 10

− 13.94

1.65

− 288.1

9a

− 3.37

− 12.05

14.84

2.49

42.1

9.15

− 254

9b

10.33

− 5.88

9.23

7.9

33.26

2.47

− 119.3

9c

− 2.72

− 15.45

1.19

− 0.83

33.66

4.88

− 136.1

  1. aMRSA
  2. bE. coli
  3. cK. pneumoniae
  4. dP. aeruginosa
  5. eA. baumannii
  6. fC. albicans
  7. gC. neoformans var. grubii